Relation of Sex and Estrogen Therapy to Serum Fibroblast Growth Factor 23, Serum Phosphorus, and Urine Phosphorus: The Heart and Soul Study
Authors:
- 1 November 2011
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 58 (5) , 737-745
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseKidney International, 2011
- Risk Factor Differences for Aortic Versus Coronary Calcified AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Relation of Serum Phosphorus Levels to Ankle Brachial Pressure Index (from the Third National Health and Nutrition Examination Survey)The American Journal of Cardiology, 2010
- FGF-23: More than a regulator of renal phosphate handling?Journal of Bone and Mineral Research, 2010
- Serum Phosphorus Levels and the Spectrum of Ankle-Brachial Index in Older Men: The Osteoporotic Fractures in Men (MrOS) StudyAmerican Journal of Epidemiology, 2010
- Serum Phosphorus Concentrations in the Third National Health and Nutrition Examination Survey (NHANES III)American Journal of Kidney Diseases, 2009
- Investigation of Gender Heterogeneity in the Associations of Serum Phosphorus With Incident Coronary Artery Disease and All-Cause MortalityAmerican Journal of Epidemiology, 2008
- Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemiaKidney International, 2008
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKDAmerican Journal of Kidney Diseases, 2008
- Fetuin-A and kidney function in persons with coronary artery disease—data from the heart and soul studyNephrology Dialysis Transplantation, 2006